Skip to main content
Terug
TMO logo

Thermo Fisher Scientific Inc.

Datakwaliteit: 100%
TMO
NYSE Healthcare Medical - Diagnostics & Research
€ 490,77
▲ € 0,48 (0,10%)
Marktkapitalisatie: 182,31B
Dagbereik
€ 482,96 € 499,95
52-Weeksbereik
€ 385,46 € 643,99
Volume
1.729.246
50D / 200D Gem.
€ 545,40 / € 514,90
Vorige Slotkoers
€ 490,29

Quick Summary

Koershistorie

Financiële Trends

Sectorvergelijking

vs Healthcare sector mediaan (631 peers)

Metriek Aandeel Sector Mediaan
P/E 27,1 0,2
P/B 3,4 3,0
ROE % 13,1 3,6
Net Margin % 15,1 3,8
Rev Growth 5Y % 3,3 10,0
D/E 0,8 0,2

Koersdoel Analisten

Hold
€ 650,58 +32.6%
Low: € 575,00 High: € 750,00
Forward K/W
19,98
Forward WPA
€ 24,57
WPA Groei (sch.)
+0,0%
Omzet Sch.
46,85B

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2030 € 36,24
€ 35,57 – € 37,18
57,24B 2
FY2029 € 32,97
€ 32,36 – € 33,82
55,65B 2
FY2028 € 29,73
€ 28,29 – € 31,07
52,56B 4

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2026-01-29 € 6,45 € 6,57 +1,9%
2025-10-22 € 5,50 € 5,79 +5,3%
2025-07-23 € 5,23 € 5,36 +2,5%
2025-04-23 € 5,10 € 5,15 +1,0%
2025-01-30 € 5,94 € 6,10 +2,7%
2024-10-23 € 5,25 € 5,28 +0,6%
2024-07-24 € 5,12 € 5,37 +4,9%
2024-04-24 € 4,71 € 5,11 +8,5%

Insider Trading Activity

20 transactions
Date Insider Type Shares Price Value
Feb 28, 2026
Lowery Frederick M.
Executive Vice President
other 897 € 521,11 € 467.435,67
Feb 25, 2026
Lowery Frederick M.
Executive Vice President
grant 1.638
Dec 4, 2025
Lagarde Michel
Executive Vice President & COO
other 81.366 € 105,17
Dec 4, 2025
Lagarde Michel
Executive Vice President & COO
sell 22.046 € 563,56 € 12.424.243,76
Dec 3, 2025
Lagarde Michel
Executive Vice President & COO
other 136.000 € 105,17
Dec 3, 2025
Lagarde Michel
Executive Vice President & COO
sell 32.000 € 583,33 € 18.668.526,38
Dec 2, 2025
Lagarde Michel
Executive Vice President & COO
other 72.000 € 105,17
Dec 2, 2025
Lagarde Michel
Executive Vice President & COO
sell 30.000 € 581,92 € 17.457.600,00
Dec 2, 2025
Lowery Frederick M.
Executive Vice President
other 13.824 € 253,99
Dec 2, 2025
Lowery Frederick M.
Executive Vice President
sell 6.912 € 581,94 € 4.022.369,28
Dec 1, 2025
Lowery Frederick M.
Executive Vice President
other 13.826 € 253,99
Dec 1, 2025
Lowery Frederick M.
Executive Vice President
sell 6.913 € 597,68 € 4.131.761,84
Nov 13, 2025
Lagarde Michel
Executive Vice President & COO
other 9.276 € 253,99
Nov 13, 2025
Lagarde Michel
Executive Vice President & COO
sell 4.638 € 594,42 € 2.756.919,96
Aug 28, 2025
Lowery Frederick M.
Executive Vice President
other 668 € 489,74 € 327.146,32
Aug 22, 2025
CASPER MARC N
Chairman & CEO
other 20.000 € 253,99
Aug 22, 2025
CASPER MARC N
Chairman & CEO
sell 10.000 € 500,40 € 5.009.586,03
Aug 20, 2025
CASPER MARC N
Chairman & CEO
other 590 € 253,99
Aug 20, 2025
CASPER MARC N
Chairman & CEO
sell 295 € 500,00 € 147.512,35
Aug 19, 2025
CASPER MARC N
Chairman & CEO
other 402 € 253,99

Dividend History

7 yr streak

Yield

0,00%

Payout Ratio

0,09%

Growth (3Y)

12,75%

Growth (5Y)

14,34%

Ex-Date Payment Date Amount Yield
Mar 13, 2026 Apr 15, 2026 € 0,47 0,38%
Dec 15, 2025 Jan 15, 2026 € 0,43 0,30%
Sep 15, 2025 Oct 15, 2025 € 0,43 0,35%
Jun 13, 2025 Jul 15, 2025 € 0,43 0,41%
Mar 14, 2025 Apr 15, 2025 € 0,43 0,31%
Dec 13, 2024 Jan 15, 2025 € 0,39 0,30%
Sep 13, 2024 Jan 15, 2025 € 0,39 0,25%
Jun 14, 2024 Jul 15, 2024 € 0,39 0,26%
Mar 14, 2024 Apr 15, 2024 € 0,39 0,25%
Dec 14, 2023 Jan 16, 2024 € 0,35 0,27%
Sep 14, 2023 Oct 13, 2023 € 0,35 0,26%
Jun 14, 2023 Jul 14, 2023 € 0,35 0,25%
Mar 14, 2023 Apr 14, 2023 € 0,35 0,22%
Dec 14, 2022 Jan 16, 2023 € 0,30 0,21%
Sep 14, 2022 Oct 14, 2022 € 0,30 0,21%
Jun 14, 2022 Jul 15, 2022 € 0,30 0,22%
Mar 15, 2022 Apr 14, 2022 € 0,30 0,20%
Dec 14, 2021 Jan 14, 2022 € 0,26 0,16%
Sep 14, 2021 Oct 15, 2021 € 0,26 0,18%
Jun 14, 2021 Jul 15, 2021 € 0,26 0,20%

Belangrijkste Punten

Revenue grew 3,25% annually over 5 years — modest growth
ROE of 13,08% — decent returns on equity
Net margin of 15,12% shows strong profitability
Generating 6,29B in free cash flow
Cash machine — converts 93,41% of earnings into free cash flow
Capital efficient — spends only 3,42% of revenue on capex

Groei

Revenue Growth (5Y)
3,25%
Revenue (1Y)3,91%
Earnings (1Y)6,35%
FCF Growth (3Y)-4,69%

Kwaliteit

Return on Equity
13,08%
ROIC6,45%
Net Margin15,12%
Op. Margin18,20%

Veiligheid

Debt / Equity
0,76
Current Ratio1,89
Interest Coverage5,71

Waardering

P/E Ratio
27,06
Forward P/E19,98
P/B Ratio3,41
EV/EBITDA26,31
Dividend Yield0,00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 3,91% Revenue Growth (3Y) 1,96%
Earnings Growth (1Y) 6,35% Earnings Growth (3Y) 6,01%
Revenue Growth (5Y) 3,25% Earnings Growth (5Y) -3,36%
Profitability
Revenue (TTM) 44,56B Net Income (TTM) 6,74B
ROE 13,08% ROA 6,11%
Gross Margin 37,66% Operating Margin 18,20%
Net Margin 15,12% Free Cash Flow (TTM) 6,29B
ROIC 6,45% FCF Growth (3Y) -4,69%
Safety
Debt / Equity 0,76 Current Ratio 1,89
Interest Coverage 5,71
Dividends
Dividend Yield 0,00% Payout Ratio 0,09%
Dividend Growth (3Y) 12,75% Dividend Growth (5Y) 14,34%
Consecutive Div Years 7 yrs
Valuation
P/E Ratio 27,06 Forward P/E 19,98
P/B Ratio 3,41 P/S Ratio 4,09
PEG Ratio 4,51 Forward PEG N/A
EV/EBITDA 26,31 Fwd EV/EBITDA 16,68
Forward P/S 3,89 Fwd Earnings Yield 5,01%
FCF Yield 3,45%
Market Cap 182,31B Enterprise Value 213,31B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 44,56B 42,88B 42,86B 44,92B 39,21B
Net Income 6,74B 6,34B 6,00B 6,95B 7,73B
EPS (Diluted) 17,74 16,53 15,45 17,64 19,46
Gross Profit 16,78B 17,73B 17,19B 19,01B 19,63B
Operating Income 8,11B 7,66B 7,45B 8,53B 10,32B

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 110,34B 97,32B 98,73B 97,15B 95,12B
Total Liabilities 56,81B 47,65B 51,88B 53,01B 54,15B
Shareholders' Equity 53,41B 49,58B 46,74B 43,98B 40,79B
Total Debt 40,86B 32,78B 36,42B 36,07B 36,34B
Cash & Equivalents 9,86B 4,01B 8,08B 8,52B 4,48B
Current Assets 28,71B 22,14B 24,59B 25,23B 20,11B
Current Liabilities 15,19B 13,33B 14,01B 17,01B 13,44B